Freenome, Inc. (FRNM)

FDA Grants Breakthrough Device Designation to Freenome's Blood-Based SimpleScreen™ Lung Cancer Screening Test

FDA approves Freenome's blood test for colorectal cancer screening

FDA Approves Freenome's SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection